维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="Borner MM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Expression of apoptosis regulatory proteins of the Bcl-2 family and P53 in primary resected non-small-cell lung cancer显示文摘	Borner MM Brousset P Pfaneer-Meyer B	1999	Br J Cancer1999，79，56：	1
2	Phase Ⅱ study of capecitablne and Oxaliplatin in first and second-line treatment of advanced or metastatic colorectal cancer 显示文摘	Borner MM Dietrich D Stupp R	2002	J Clin Oncol2002，20，：	1
3	Phase Ⅱ study of capecitabine and oxaliplatin in first-and second-line treatment of advanced or metastatic colorectal cancer 显示文摘	Borner MM	2002	Clin Oncol2002，20，7：	1
4	Phase I study of capecitabine and oxaliplatin in first and second-line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	J Clinl Oncol2002，20，7：	1
5	Phase Ⅱ study of capecitabine and oxaliplatin in first and second-line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	Clin Oncol2002，20，7：	1
6	Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer too good to be true显示文摘	Borner MM	1999	Ann Oncol1999，10，6：	1
7	Phase Ⅱ study of capecitabine and oxaliplatin in first-and secong-line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	Clin Oncol2002，20，7：	1
8	A randomised phase Ⅱ trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity 显示文摘	Borner MM Bernhard J Dietrich D	2005	Ann Oneol2005，16，2：	1
9	Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer-too good to be true?显示文摘	Borner MM	1999	Ann Oncol1999，10，6：	1
10	Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluoreuracil and leucovorin:a randomised crossover trial in advanced colorectal cancer 显示文摘	Borner MM Schoffski P de Wit R	2002	Eur J Cancer2002，38，3：	1
11	Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer - too good to be true显示文摘	Borner MM	1999	Ann Oncol1999，10，6：	1
12	Phase I1 study of capecit- abine and oxaliplatin in first-and second-line treatment of advanced or metastatic colorectal cancer 显示文摘	Borner MM Dietrich D Stupp R	2002	J Clin Oncol2002，20，7：	1
13	Phase Ⅱ study of capecitabine and oxaliphtin in first- and second- line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	J CAin Oncol2002，20，7：	1
14	Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cells显示文摘	Borner MM Jonocourt F Hotz MA	1997	Brit J Cancer1997，76，：	1
15	Phase Ⅱ study of capecitabine and oxaliplatin in first-and second-line treatment of advanced or metastaic colorectal cancer显示文摘	Borner MM Dierich D Stupp R	2002	J Clin Oncal2002，20，7：	1
16	Phase Ⅱ study of capecitabine and oxaliplatin in first-and second-line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	J Clin Oncol2002，20，7：	1
17	Bioavailability and feasibility of subcutaneous 5-fluouracil显示文摘	Borner MM Kneer J Crevoisier C	1993	Br-J-Cancer1993，68，3：	1
18	A randomized phase 1I trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity显示文摘	Borner MM Bernhard J Dietrich D	2005	Ann Oncol2005，16，2：	1
19	Phase Ⅱ study of The combination of capecitabine and oxaliplatin in first and second line treatment of advanced or metastatic colorectalcancer 显示文摘	Borner MM Dietrich D Stupp R	2002	J Clin Cncol2002，20，7：	1
20	Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer:evidence in terms of response rate显示文摘	Borner MM Sartor O	1992	J Clin Oncol1992，10，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示